The Medicines Act 1968: What the 2026 update means for medical cleanrooms
Last December, the Humans Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 was made by the Privy Council, following approval by Parliament, as an effort to maximise workforce flexibility and enable pharmacists to spend more time delivering patient-facing care.
Amendments to the Medicines Act 1968 and the Human Medicines Regulations 2012 are set to come into force in two stages; the first being in January 2026 and the second due on 10 December 2026.
In this blog, we’ll break down the upcoming legislative amendments, what this means for your medical cleanroom, and how you can get your facility ready for the changes.
What are the Medicines Act 1968 and Human Medicines Regulations 2012?
The Medicines Act 1968 and the Human Medicines Regulations 2012 are the legal frameworks that govern both private and public organisations in relation to the manufacturing, processing, handling, and sale of medicinal products.
Under the current framework, certain preparation, assembly, dispensing, sale, and supply activities must be carried out by, or under the supervision of, a pharmacist. Scheduled updates to these frameworks are being made to give greater flexibility on authorising competent, trained pharmacy team members to perform and oversee tasks that were previously the sole responsibility of the registered pharmacist.
January 2026: What’s changed?
The first phase of the Human Medicines (Authorisation by Pharmacist and Supervision by Pharmacy Technicians) Order 2025 came into effect on 7 January 2026, specifically allowing a pharmacist to authorise a suitable, trained, and competent member of the pharmacy team to hand out a checked and bagged prescription, even if the pharmacist is temporarily absent from the premises.
December 2026: What’s changing?
The second phase, due to come into effect on 10 December 2026, will place greater emphasis on delegating responsibilities and utilising the skills and expertise across the pharmacy team.
For registered pharmacies, this phase will allow a pharmacist to authorise a pharmacy technician to carry out or supervise certain preparation, assembly, dispensing, and supply activities.
The introduction of Regulation 4A of the Human Medicines Regulations 2012, as part of the 2025 Order, specifically relate to the updates within hospital aseptic facilities. Pharmacy technicians within these aseptic facilities (including medical cleanrooms that prepare treatments like chemotherapy within a hospital) can take primary responsibility for the preparation, assembly, and dispensing of medicinal products, with the chief pharmacist maintaining overarching responsibility for the safe and effective running of the pharmacy service.
The government states that these legislative changes will help give pharmacists more time to deliver direct, patient-facing care alongside other medical professionals. Additionally, the update will allow for pharmacy technicians to take on a higher degree of professional accountability and utilise their expertise and judgement, facilitating faster delivery of care and medicinal services.
What do these updates mean for medical cleanrooms?
From its introduction in December 2025, facilities intending to adopt these new arrangements are provided with a 12-month transition period to prepare for the legislative updates. This period provides an opportunity to review competency frameworks, training, and documentation before 10 December 2026. Some areas could include:
- SOPs, auditing processes, and authorisation logs may need to be reviewed and updated to accurately define how authority is appointed, how competency is determined, and the responsibilities for pharmacy teams.
- Provide training across fundamental cleanroom best practices and processes, specifically in relation to the guidance outlined as part of ISO 14644 and EU GMP, ensuring operators understand the correlation between contamination control and human behaviour.
- As responsibilities are delegated and demand for aseptically prepared medicines continues to grow, contamination control will remain crucial to ensure product quality and environmental integrity via decontamination regimes, gowning protocols, and particulate monitoring.
At Connect 2 Cleanrooms, we can support your medical cleanroom with preparing for the upcoming updates. Our large selection of cleanroom consumables including aseptic and sterile PPE, cleaning and disinfectants, and monitoring equipment can help keep production running smoothly while maintaining patient safety. Our range of CPD-certified training courses, including ISO 14644, EU GMP, and GDocP, upskills your team with the latest guidance and best practices to support the maintenance of a contamination-controlled environment and good documentation practices.
For more guidance on this year’s legislative changes, speak to a member of our team. If you need support with implementing compliant cleanroom consumables, GDocP principles, or upskilling your operators, contact us below.
